The mechanisms by which the ketone body D-β-Hydroxybutyrate may improve the multiple cellular pathologies of Parkinson's disease
Parkinson's disease, a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, is strongly associated with the death of dopaminergic neurons in the brain's substantia nigra. Although dopamine replacement therapy temporarily helps patients manage their motor sy...
Main Authors: | Norwitz, N, Hu, M, Clarke, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2019
|
Similar Items
-
Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator
by: Cameron G. McCarthy, et al.
Published: (2021-10-01) -
Ketone body β-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics
by: I. Llorente-Folch, et al.
Published: (2023-11-01) -
Why a d-β-hydroxybutyrate monoester?
by: Soto-Mota, A, et al.
Published: (2020) -
Exogenous ketones as a metabolic intervention for Parkinson’s disease
by: Norwitz, N
Published: (2020) -
Ketone body therapy with D/L-β-hydroxybutyric acid solution in severe MADD
by: Tobias Fischer, et al.
Published: (2019-09-01)